Notable

Notable company information, Employees & Contact Information

Explore related pages

Related company profiles:

Notable is a clinical-stage platform therapeutic company developing a new class of precision medicines: predictive precision medicines. Notable aims to be the leader in predictive precision medicine and revolutionize the way in which patients seek and receive treatment: patient population by patient population, and cancer by cancer. By transforming historical standards of care, Notable expects to provide dramatic impact for patients and the healthcare community. Notable’s proprietary Predictive Precision Medicines Platform replicates ex vivo the clinical response of patients to cancer treatments with high fidelity, through its optimized integration of biological assay conditions, dynamic signal analysis, and AI-driven in-silico translation into predictive algorithms. Using its high-fidelity platform, Notable can identify and select clinically responsive patients prior to their treatment and fast-track clinical development in this patient population. Notable has created a targeted, triple de-risked in-licensing strategy and a fast-track clinical development approach that delivers a product’s medical impact and commercial value faster, higher, and more likely than traditional drug development.

Company Details

Employees
34
Founded
-
Address
320 Hatch Dr, Foster City,california,united States
Email
in****@****abs.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Burlington.
HQ
Foster City, California
Looking for a particular Notable employee's phone or email?

Notable Questions

News

Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay - ASCO Publications

Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay ASCO Publications

Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug - Fierce Biotech

Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug Fierce Biotech

Notable Announces $40M Series B Round to Fuel Development - GlobeNewswire

Notable Announces $40M Series B Round to Fuel Development GlobeNewswire

Notable Names Dr. Thomas A. Bock as CEO - Newswire.com

Notable Names Dr. Thomas A. Bock as CEO Newswire.com

Notable Labs Closes Merger Transaction With VBL Therapeutics - Yahoo Finance

Notable Labs Closes Merger Transaction With VBL Therapeutics Yahoo Finance

Notable Expands Executive Leadership Team with Appointment of Dr. Kevin Lynch as Chief Business Officer - Business Wire

Notable Expands Executive Leadership Team with Appointment of Dr. Kevin Lynch as Chief Business Officer Business Wire

Notable Labs hopes for success with Boehringer’s failed AML drug - Clinical Trials Arena

Notable Labs hopes for success with Boehringer’s failed AML drug Clinical Trials Arena

Notable Labs files for bankruptcy, board resigns - Investing.com

Notable Labs files for bankruptcy, board resigns Investing.com

Cancer-focused biotech Notable Labs lays off 65% of workforce - The Business Journals

Cancer-focused biotech Notable Labs lays off 65% of workforce The Business Journals

Notable Appoints Biotech Veteran Joseph Wagner PhD as Chief Scientific Officer - GlobeNewswire

Notable Appoints Biotech Veteran Joseph Wagner PhD as Chief Scientific Officer GlobeNewswire

Notable Labs lands $40M to expand AI-based cancer treatment tech - Fierce Biotech

Notable Labs lands $40M to expand AI-based cancer treatment tech Fierce Biotech

Notable Labs Announces CEO Transition - GlobeNewswire

Notable Labs Announces CEO Transition GlobeNewswire

Y Combinator demo-thon: Check out 5 favorites from Day 2 - The Business Journals

Y Combinator demo-thon: Check out 5 favorites from Day 2 The Business Journals

After a tough year, VBL merges with Notable Labs - Fierce Biotech

After a tough year, VBL merges with Notable Labs Fierce Biotech

VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement - GlobeNewswire

VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement GlobeNewswire

Notable Labs launches rolling blood cancer trial to test its AI system - Fierce Biotech

Notable Labs launches rolling blood cancer trial to test its AI system Fierce Biotech

Top Notable Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant